Leucine Stabilizes Mitochondrial Proteins to Boost Cellular Respiration
A single amino acid, leucine, suppresses the breakdown of outer mitochondrial membrane proteins, expanding mitochondrial capacity and enhancing metabolic respiration.
Summary
Researchers at the University of Cologne discovered that leucine, a branched-chain amino acid abundant in protein-rich foods, directly regulates mitochondrial protein quality control. When leucine is plentiful, it inhibits the amino acid sensor GCN2, which in turn reduces levels of the ubiquitin ligase cofactor SEL1L at mitochondria. This prevents the breakdown of outer mitochondrial membrane proteins — including key components of the protein import machinery — effectively expanding the mitochondrial proteome and boosting respiratory capacity. Disrupting leucine catabolism impaired fertility in C. elegans under stress, and human lung cancer cells with elevated leucine levels showed reduced mitochondrial protein ubiquitylation and resistance to mitochondrial import inhibitors. The findings reveal a conserved leucine–GCN2–SEL1L signaling axis linking nutrient availability to mitochondrial remodeling.
Detailed Summary
Why this matters: Mitochondria are central to cellular energy production and must dynamically remodel their protein composition in response to changing metabolic demands. While nutrient sensing pathways like mTOR are well-studied, the specific molecular mechanisms linking individual amino acids to mitochondrial protein turnover have remained largely unknown. This study identifies a previously unrecognized axis connecting leucine availability directly to outer mitochondrial membrane (OMM) proteostasis and respiratory function — with broad implications for aging, metabolic disease, and cancer biology.
What was studied: Using a novel GFP-based ubiquitin fusion degradation (UFD) reporter system in C. elegans — the mitoUFD construct, fusing non-cleavable ubiquitin–GFP to the transmembrane domain of the OMM protein FIS-1 — the team performed systematic genetic screens across 135 amino acid metabolism genes and 38 mitochondrial pathway genes. They supplemented worms with individual branched-chain amino acids (BCAAs) and conducted parallel experiments in HEK293 cells and human lung cancer cell lines (NCI-H1299 and A549).
Key results: The screen revealed that knockdown of 67 out of 135 amino acid metabolism genes stabilized mitoUFD by more than 10%. Five of the top hits belonged to the leucine catabolic pathway. Direct leucine supplementation at 20 mM and 50 mM significantly stabilized mitoUFD (p<0.05, two-way ANOVA), while isoleucine and valine had no effect at equivalent concentrations. RNAi knockdown of GCN2 abolished the leucine-induced stabilization of mitoUFD, confirming GCN2 as the leucine sensor in this pathway. Mechanistically, leucine suppresses GCN2 activity, which reduces SEL1L — a cofactor of the HRD1 E3 ubiquitin ligase — specifically at mitochondria. Knockdown of SEL1L phenocopied leucine supplementation, elevating OMM protein abundance and measurably increasing mitochondrial oxygen consumption rates. Proteomic analysis confirmed that leucine or SEL1L depletion broadly stabilized OMM-resident proteins, particularly components of the TOM complex (TOMM20, TOMM40, TOMM70) involved in mitochondrial protein import.
Disease-relevant findings: A disease-associated missense mutation in BCAT2 (branched-chain aminotransferase 2), a key enzyme in leucine catabolism, stabilized OMM proteins and impaired fertility in C. elegans under thermal stress — connecting defects in leucine metabolism to organismal fitness. In human NCI-H1299 and A549 lung cancer cells, which harbor elevated intracellular BCAA levels, OMM ubiquitylation was reduced and cells were significantly more resistant to the mitochondrial import inhibitor MitoBloCK-6, suggesting that the leucine–GCN2–SEL1L axis is functionally active in human cancer and may contribute to treatment resistance.
Implications and caveats: This study defines a conserved nutrient-sensing mechanism by which leucine tunes mitochondrial proteostasis and respiratory capacity. For longevity science, it raises important questions about how chronic leucine supplementation — already popular in the context of muscle protein synthesis — might influence mitochondrial remodeling across tissues and during aging. The work is primarily mechanistic, conducted in C. elegans and cell lines; the physiological relevance of specific leucine concentrations used in vitro to normal dietary leucine levels in humans remains to be established. Translation to mammalian physiology in vivo and aging contexts will require further study.
Key Findings
- Leucine supplementation at 20 mM and 50 mM significantly stabilized OMM-anchored mitoUFD reporter proteins compared to 0 mM control (p<0.05, two-way ANOVA with Holm–Sidak correction); isoleucine and valine had no equivalent effect
- 67 out of 135 amino acid metabolism genes stabilized mitoUFD by >10% when knocked down; 5 of the top 16 hits (>20% increase) belonged specifically to the leucine catabolic pathway
- RNAi knockdown of the amino acid sensor GCN2 abolished leucine-induced mitoUFD stabilization, placing GCN2 as the required mediator of leucine sensing in this pathway
- Knockdown of SEL1L (HRD1 E3 ligase cofactor) phenocopied leucine supplementation, elevating OMM protein abundance and increasing mitochondrial oxygen consumption rates in both C. elegans and human cell lines
- Proteasome inhibition with bortezomib (BTZ) at 5–10 µM stabilized mitoUFD but not mitoGFP control, confirming UPS-mediated degradation; CDC-48/p97 knockdown also accumulated polyubiquitylated mitoUFD
- BCAT2 disease-associated mutation stabilized OMM proteins and impaired fertility under thermal stress in C. elegans, linking aberrant leucine catabolism to organismal fitness defects
- Human lung cancer cells (NCI-H1299, A549) with elevated intracellular BCAA levels showed reduced OMM ubiquitylation and significantly increased resistance to the mitochondrial import inhibitor MitoBloCK-6
Methodology
The study employed a newly developed mitoUFD GFP-based reporter system in C. elegans, fusing non-cleavable ubiquitin–GFP to the FIS-1 transmembrane domain to track UPS-mediated OMM protein degradation. Systematic RNAi screens covered 135 amino acid metabolism genes and 38 mitochondrial pathway genes, with fluorescence imaging quantified by ImageJ and worm sorter (50–250 animals per gene). Leucine supplementation experiments used 20–50 mM concentrations with 3-hour treatment windows, and parallel experiments were conducted in HEK293 and human lung cancer cell lines (NCI-H1299, A549). Statistical analyses included two-way ANOVA with Holm–Sidak correction, one-way ANOVA with Fisher's LSD test, and unpaired two-tailed t-tests; cycloheximide chase assays (up to 9 hours) with n=5–8 independent biological replicates were used to assess protein turnover kinetics.
Study Limitations
The mechanistic experiments were conducted primarily in C. elegans and human cell lines, so the physiological concentrations of leucine used in vitro (1–50 mM) may not directly reflect normal dietary leucine levels achievable in human tissues. The study does not directly address age-related changes in this pathway or demonstrate efficacy in a mammalian aging model in vivo. No conflicts of interest were declared by the authors; funding was provided by the Deutsche Forschungsgemeinschaft and the Alexander von Humboldt Foundation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: